FORT LAUDERDALE, Fla., June 7 /PRNewswire-FirstCall/ -- Imaging Diagnostic Systems, Inc., a pioneer in laser optical breast imaging systems, participated in the 2nd National Imaging Diagnostic Conference on Breast Disease in Qingdao, China, May 25-27, 2007. The Conference is considered the most important venue on breast disease in China.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGO )
Dr. Run-Xian Bao, Chairman of the Tianjin Tumor Hospital Radiology Department, the largest breast disease center in China, gave an introductory presentation on the new CT Laser Mammography (CTLM(R)) clinical technology. The CTLM presentation was published in the collective articles of the conference.
"Approximately 180 doctors attended this conference, the leaders in the study of breast cancer. Many were very interested in how CT Laser Mammography systems could help improve cancer detection methods or be used to track a patient's progress through neoadjuvant therapy," stated Mr. Jing Jie Zhuang, Managing Director, IDSI Beijing.
"We are very pleased with the growing interest we are seeing as we build our clinical presence in China. Having a direct office in Beijing has greatly helped IMDS establish close relations with leading Chinese breast specialists for both research and commercial opportunities. Beijing Friendship Hospital has been a key CTLM clinical collaborator," Zhuang continued.
IMDS has received approval for the CTLM system from the State Food and Drug Administration of the People's Republic of China (SFDA), the Chinese equivalent of the US Food and Drug Administration. As announced previously, according to the Beijing Municipal Commission of Development & Reform and the Beijing Municipal Health Bureau, CTLM procedures may be priced up to RMB300 ($38 at the current exchange rate) per breast as listed on the "Interim Procedures for Beijing Medical Service Price" schedule.
About Imaging Diagnostic Systems, Inc.
Imaging Diagnostic Systems, Inc. has developed a revolutionary new imaging device to aid in the detection and management of breast cancer. The CTLM(R) system is a breast imaging system that utilizes patented continuous wave laser technology and computer algorithms to create 3-D images of the breast. The procedure is non-invasive, painless, and does not expose the patient to ionizing radiation or painful breast compression. CT Laser Mammography (CTLM(R)) is designed to be used in conjunction with mammography. It reveals information about blood distribution in the breast and may visualize the process of angiogenesis, which usually accompanies tumor growth.
Imaging Diagnostic Systems is currently collecting data from clinical sites for the future filing of an FDA Premarket Approval (PMA) application for the Computed Tomography Laser Mammography (CTLM(R)) system to be used as an adjunct to mammography. The FDA has determined that the Company's clinical study is a non-significant risk (NSR) investigational device study under 812.3(m) of the investigational device exemptions (IDE) regulation (21 CFR 812). The CTLM system is limited by United States Federal Law to investigational use only in the United States. The CTLM system has received other registrations including CE, CMDCAS Canadian License, China SFDA, UL, ISO 9001:2000, ISO 13485:2003 and FDA export certification.
For more information, visit our website: www.imds.com
As contemplated by the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act of 1995, this news release may contain forward-looking statements pertaining to future, anticipated, or projected plans, performances and developments, as well as other statements relating to future operations. All such forward-looking statements are necessarily only estimates or predictions of future results or events and there can be no assurance that actual results or events will not materially differ from expectations. Further information on potential factors that could affect Imaging Diagnostic Systems, Inc., is included in the Company's filings with the Securities and Exchange Commission. We expressly disclaim any intent or obligation to update any forward-looking statements.
Investor Relations: Rick Lutz (404) 261-1196 lcgroup@mindspring.com Media Contact: Elizabeth Williams (954) 581-9800 williams@imds.com
Photo: http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comImaging Diagnostic Systems, Inc.CONTACT: Investors, Rick Lutz, +1-404-261-1196, lcgroup@mindspring.com,for Imaging Diagnostic Systems; or Media, Elizabeth Williams of ImagingDiagnostic Systems, +1-954-581-9800, williams@imds.com
Web site: http://www.imds.com//
